Back
Outlook Therapeutics Stock Price Chart
Sell
49
OTLK
Outlook Therapeutics
Last Price:
7.83
Seasonality Move:
-0.16%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OTLK is experiencing slight selling pressure.
Outlook Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.66 | Buy |
| 20-day SMA: | 8.08 | Sell |
| 50-day SMA: | 8.37 | Sell |
| 200-day SMA: | 9.49 | Sell |
| 8-day EMA: | 7.82 | Buy |
| 20-day EMA: | 8 | Buy |
| 50-day EMA: | 8.24 | Sell |
| 200-day EMA: | 11.23 | Sell |
Outlook Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 48.4 | Sell |
| Chaikin Money Flow: | -62211 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.65 - 8.55) | Sell |
| Bollinger Bands (100): | (7.39 - 9.07) | Sell |
Outlook Therapeutics Technical Analysis
| May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Outlook Therapeutics Stock
Is Outlook Therapeutics Stock a Buy?
- Outlook Therapeutics share price is 8.00 while OTLK 8-day simple moving average is 7.66, which is a Buy signal.
- The stock price of OTLK is 8.00 while Outlook Therapeutics 20-day SMA is 8.08, which makes it a Sell.
- Outlook Therapeutics 50-day simple moving average is 8.37 while OTLK share price is 8.00, making it a Sell technically.
- OTLK stock price is 8.00 and Outlook Therapeutics 200-day simple moving average is 9.49, creating a Sell signal.
OTLK Technical Analysis vs Fundamental Analysis
Sell
49
Outlook Therapeutics (OTLK)
is a Sell
Is Outlook Therapeutics a Buy or a Sell?
-
Outlook Therapeutics stock is rated a Sell
The current Outlook Therapeutics [OTLK] share price is $8.00. The Score for OTLK is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Outlook Therapeutics Stock Info
Market Cap:
187.24M
Price in USD:
8.00
Share Volume:
224.92K
Outlook Therapeutics 52-Week Range
52-Week High:
40.60
52-Week Low:
4.00
Sell
49
Outlook Therapeutics (OTLK)
is a Sell
Outlook Therapeutics Share Price Forecast
-
What is the Outlook Therapeutics stock price today?
The Outlook Therapeutics stock price is 8.00 USD today. -
Will OTLK stock go up or go down?
Outlook Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Outlook Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Outlook Therapeutics is overvalued.
Is Outlook Therapeutics Stock a Buy?
- Outlook Therapeutics share price is 8.00 while OTLK 8-day exponential moving average is 7.82, which is a Buy signal.
- The stock price of OTLK is 8.00 while Outlook Therapeutics 20-day EMA is 8.00, which makes it a Buy.
- Outlook Therapeutics 50-day exponential moving average is 8.24 while OTLK share price is 8.00, making it a Sell technically.
- OTLK stock price is 8.00 and Outlook Therapeutics 200-day simple moving average is 11.23, creating a Sell signal.
Fundamental Analysis of Outlook Therapeutics
Is Outlook Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.35 per share, an increase this year of $0.49 per share, and an increase next year of $1.74 per share.
Technical Analysis of Outlook Therapeutics
Should I short Outlook Therapeutics stock?
- OTLK Moving Average Covergence Divergence (MACD) indicator is -0.21, suggesting Outlook Therapeutics is a Sell
- Outlook Therapeutics Relative Strength Index (RSI) is 48.4, which suggest Outlook Therapeutics is oversold
- The Bollinger Bands (25) for Outlook Therapeutics is (7.65 - 8.55), which suggest Outlook Therapeutics is a Sell
- The Bollinger Bands (100) for Outlook Therapeutics is (7.39 - 9.07), which suggest Outlook Therapeutics is a Sell
* Outlook Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.